Annual Total Debt:
$495.70M+$35.30M(+7.67%)Summary
- As of today (September 17, 2025), NBIX annual total debt is $495.70 million, with the most recent change of +$35.30 million (+7.67%) on December 31, 2024.
- During the last 3 years, NBIX annual total debt has risen by +$38.80 million (+8.49%).
- NBIX annual total debt is now -1.62% below its all-time high of $503.85 million, reached on December 31, 2019.
Performance
NBIX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$489.80M-$3.30M(-0.67%)Summary
- As of today (September 17, 2025), NBIX quarterly total debt is $489.80 million, with the most recent change of -$3.30 million (-0.67%) on June 30, 2025.
- Over the past year, NBIX quarterly total debt has increased by +$198.20 million (+67.97%).
- NBIX quarterly total debt is now -10.44% below its all-time high of $546.90 million, reached on March 31, 2024.
Performance
NBIX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
NBIX Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.7% | +68.0% |
3 y3 years | +8.5% | +71.4% |
5 y5 years | -1.6% | -4.5% |
NBIX Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +76.8% | -10.4% | +79.0% |
5 y | 5-year | -1.6% | +76.8% | -10.4% | +79.0% |
alltime | all time | -1.6% | >+9999.0% | -10.4% | >+9999.0% |
NBIX Total debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $489.80M(-0.7%) |
Mar 2025 | - | $493.10M(-0.5%) |
Dec 2024 | $495.70M(+7.7%) | $495.70M(+73.2%) |
Sep 2024 | - | $286.20M(-1.9%) |
Jun 2024 | - | $291.60M(-46.7%) |
Mar 2024 | - | $546.90M(+18.8%) |
Dec 2023 | $460.40M(+64.3%) | $460.40M(+68.3%) |
Sep 2023 | - | $273.60M(-1.0%) |
Jun 2023 | - | $276.50M(-0.6%) |
Mar 2023 | - | $278.30M(-0.7%) |
Dec 2022 | $280.30M(-38.7%) | $280.30M(-1.0%) |
Sep 2022 | - | $283.10M(-0.9%) |
Jun 2022 | - | $285.70M(-42.5%) |
Mar 2022 | - | $497.10M(+8.8%) |
Dec 2021 | $456.90M(+8.1%) | $456.90M(+1.0%) |
Sep 2021 | - | $452.60M(+0.5%) |
Jun 2021 | - | $450.30M(+1.9%) |
Mar 2021 | - | $441.70M(+4.5%) |
Dec 2020 | $422.60M(-16.1%) | $422.60M(-18.4%) |
Sep 2020 | - | $517.70M(+0.9%) |
Jun 2020 | - | $513.00M(+0.9%) |
Mar 2020 | - | $508.50M(+0.9%) |
Dec 2019 | $503.85M(+29.7%) | $503.85M(+3.6%) |
Sep 2019 | - | $486.23M(+3.8%) |
Jun 2019 | - | $468.40M(+1.0%) |
Mar 2019 | - | $463.85M(+19.4%) |
Dec 2018 | $388.50M(+5.1%) | $388.50M(+1.3%) |
Sep 2018 | - | $383.65M(+1.3%) |
Jun 2018 | - | $378.88M(+1.2%) |
Mar 2018 | - | $374.21M(+1.2%) |
Dec 2017 | $369.62M(>+9900.0%) | $369.62M(+1.2%) |
Sep 2017 | - | $365.11M(+1.2%) |
Jun 2017 | - | $360.68M(>+9900.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2008 | - | $109.02M(-0.3%) |
Jun 2008 | - | $109.35M(-0.4%) |
Mar 2008 | - | $109.77M(-0.4%) |
Dec 2007 | $110.23M(+105.5%) | $110.23M(+119.9%) |
Sep 2007 | - | $50.13M(-2.1%) |
Jun 2007 | - | $51.20M(-2.3%) |
Mar 2007 | - | $52.40M(-2.3%) |
Dec 2006 | $53.64M(-9.7%) | $53.64M(-2.5%) |
Sep 2006 | - | $54.99M(-2.6%) |
Jun 2006 | - | $56.45M(-2.6%) |
Mar 2006 | - | $57.95M(-2.4%) |
Dec 2005 | $59.40M(-10.2%) | $59.40M(-2.6%) |
Sep 2005 | - | $60.99M(-2.6%) |
Jun 2005 | - | $62.63M(-2.8%) |
Mar 2005 | - | $64.41M(-2.6%) |
Dec 2004 | $66.13M(+81.5%) | $66.13M(-3.7%) |
Sep 2004 | - | $68.70M(+16.7%) |
Jun 2004 | - | $58.88M(+24.9%) |
Mar 2004 | - | $47.13M(-31.6%) |
Dec 2003 | $36.43M(+359.1%) | $68.91M(+205.9%) |
Sep 2003 | - | $22.53M(+0.3%) |
Jun 2003 | - | $22.47M(+170.6%) |
Mar 2003 | - | $8.30M(+4.6%) |
Dec 2002 | $7.93M(+39.5%) | $7.93M(+18.6%) |
Sep 2002 | - | $6.69M(+19.6%) |
Jun 2002 | - | $5.59M(+9.3%) |
Mar 2002 | - | $5.12M(-10.1%) |
Dec 2001 | $5.69M(+47.0%) | $5.69M(+52.2%) |
Sep 2001 | - | $3.74M(-10.3%) |
Jun 2001 | - | $4.16M(+18.2%) |
Mar 2001 | - | $3.52M(-8.9%) |
Dec 2000 | $3.87M(+24.3%) | $3.87M(+26.6%) |
Sep 2000 | - | $3.06M(+16.1%) |
Jun 2000 | - | $2.63M(-8.4%) |
Mar 2000 | - | $2.87M(-7.7%) |
Dec 1999 | $3.11M(+0.8%) | $3.11M(-1.2%) |
Sep 1999 | - | $3.15M(-3.7%) |
Jun 1999 | - | $3.27M(-7.9%) |
Mar 1999 | - | $3.56M(+15.1%) |
Dec 1998 | $3.09M(+93.7%) | $3.09M(-56.3%) |
Sep 1998 | - | $7.07M(+57.2%) |
Jun 1998 | - | $4.50M(-19.3%) |
Mar 1998 | - | $5.57M(+248.4%) |
Dec 1997 | $1.59M(-2.2%) | $1.60M(>+9900.0%) |
Sep 1997 | - | $0.00(0.0%) |
Jun 1997 | - | $0.00(0.0%) |
Mar 1997 | - | $0.00(-100.0%) |
Dec 1996 | $1.63M | $1.60M(>+9900.0%) |
Sep 1996 | - | $0.00(0.0%) |
Jun 1996 | - | $0.00(-100.0%) |
Mar 1996 | - | $2.20M |
FAQ
- What is Neurocrine Biosciences, Inc. annual total debt?
- What is the all time high annual total debt for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual total debt year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly total debt?
- What is the all time high quarterly total debt for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly total debt year-on-year change?
What is Neurocrine Biosciences, Inc. annual total debt?
The current annual total debt of NBIX is $495.70M
What is the all time high annual total debt for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual total debt is $503.85M
What is Neurocrine Biosciences, Inc. annual total debt year-on-year change?
Over the past year, NBIX annual total debt has changed by +$35.30M (+7.67%)
What is Neurocrine Biosciences, Inc. quarterly total debt?
The current quarterly total debt of NBIX is $489.80M
What is the all time high quarterly total debt for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly total debt is $546.90M
What is Neurocrine Biosciences, Inc. quarterly total debt year-on-year change?
Over the past year, NBIX quarterly total debt has changed by +$198.20M (+67.97%)